Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Past Updates from the Clinician Registry Listserv

Update Sent February 27, 2006

NOTE: This document is provided for historical purposes only and may not provide our most accurate and up-to-date information. The most current Clinician's information can be found on the Clinician Home Page.

UPDATES TO INFORMATION AND GUIDANCE
The following updates were made to CDC information and guidance from February 21-27, 2006, or reflect current events. If you have any questions on these or other clinical issues, please write to us at coca@cdc.gov.

Today's topics Include:


Anthrax

CDC Health Update: Inhalation Anthrax Case Investigation, Pennsylvania, New York City –
Laboratory testing from the patient’s storage/work facility, his van and his residence have identified Bacillus anthracis. These findings are consistent with the hypothesis that the patient’s exposure occurred while working on contaminated hides while making traditional drums.
http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00242

CDC Health Update: Inhalation Anthrax Case in Pennsylvania -
On February 16, 2006, a 44-year-old man presented to a hospital in Pennsylvania with respiratory symptoms including dry cough, shortness of breath, and general malaise. Laboratory Response Network (LRN) and Polymerase Chain Reaction (PCR) on 2/21 and gamma phage lysis on 2/22 from blood culture isolate were positive for Bacillus anthracis.
http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00241

Algorithm for Laboratory Diagnosis of Anthrax
Aide to the identification of inhalation or cutaneous anthrax and flow chart of diagnostic testing.
http://www.bt.cdc.gov/agent/anthrax/lab-testing/algorithm.asp

Inhalation Anthrax: Recommended Specimens for Microbiology and Pathology for Diagnosis
Specimens should be collected from any patient being evaluated for inhalation Bacillus anthracis infection. This includes cases of known exposure or high risk of exposure (including bioterrorism events where agent is unconfirmed), or cases with a clear epidemiologic link to exposure with presence of inhalation anthrax symptoms, or cases where there is evidence of symptoms compatible with anthrax, but with no diagnosis.
http://www.bt.cdc.gov/agent/anthrax/lab-testing/inhalationspecimens.asp

Cutaneous Anthrax: Recommended Specimens for Microbiology and Pathology for Diagnosis
Specimens should be collected from any patient being evaluated for cutaneous Bacillus anthracis infection.
http://www.bt.cdc.gov/agent/anthrax/lab-testing/cutaneousspecimens.asp

Anthrax: Collecting, Preparing, and Shipping Serum Samples to CDC for Serology Testing
http://www.bt.cdc.gov/agent/anthrax/lab-testing/cdcspecimens.asp

Acceptable Biological Specimens Needed for Laboratory Testing for Anthrax -
Chart reviewing recommendations for specimens to submit for Anthrax testing.
http://www.bt.cdc.gov/agent/anthrax/lab-testing/anthraxspecimens.asp

 

Avian Influenza

Avian Influenza: Current Situation -
Austria, Egypt, and France added to list of countries reporting animal cases.
On this page: Summary, human H5N1 cases, animal H5N1 cases, assessment of current situation, bird import ban, travel, and CDC response.
http://www.cdc.gov/flu/avian/outbreaks/current.htm

Embargo of Birds from Specified Countries
Based on concerns about highly pathogenic avian influenza (HPAI) H5N1 virus and its potential to cause illness in humans, CDC and the U.S. Department of Agriculture (USDA) have taken steps to prevent importation of birds and bird products from countries with the virus: Cambodia, China, Indonesia, Japan, Laos, Malaysia, South Korea, Thailand, Vietnam, Kazakhstan, Romania, Russia, Turkey, Ukraine and Nigeria.
On February 22, 2006, CDC issued an amendment adding India to its current embargo after H5N1 was confirmed in poultry.
http://www.cdc.gov/flu/avian/outbreaks/embargo.htm

Outbreak Notice
Update: Human Infection with Avian Influenza A (H5N1) Virus -
Avian influenza A (H5N1) viruses usually affect wild birds but have infected and caused serious disease among poultry, such as chickens. Human infections with H5N1 viruses are rare, but have also occurred in several countries since 2003.
http://wwwn.cdc.gov/travel/contentAvianFluAsia.aspx

Outbreak Notice
Update: Guidelines and Recommendations
Interim Guidance about Avian Influenza A (H5N1) for U.S. Citizens Living Abroad
-
http://wwwn.cdc.gov/travel/contentAvianFluAmericansAbroad.aspx

 

Seasonal Influenza

Current Weekly Flu Report -

During week 7 (February 12 – February 18, 2006)*, influenza activity increased in the United States. Four hundred thirty-seven specimens (15.3%) tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories were positive for influenza. The proportion of patient visits to sentinel providers for influenza-like illness (ILI) was above the national baseline. The proportion of deaths attributed to pneumonia and influenza was below the baseline level. Seventeen states and New York City reported widespread influenza activity; 18 states reported regional influenza activity; 10 states reported local influenza activity; 4 states and Puerto Rico reported sporadic influenza activity; and the District of Columbia reported no activity.
http://www.cdc.gov/flu/weekly/

Flu Activity Reports -

Weekly Surveillance Reports
http://www.cdc.gov/flu/weekly/fluactivity.htm

 

Emergency Preparedness

Laboratory Testing for Ricin
This fact sheet provides a brief outline of how laboratory testing is done on environmental samples or human clinical specimens that may contain ricin, a poisonous protein from the castor bean plant.
http://www.bt.cdc.gov/agent/ricin/labtesting.asp

 


Our Clinician Communication Team is committed to excellence in reporting our weekly updates.  Please e-mail coca@cdc.gov should you note any written errors or discrepancies.

If you need to unsubscribe or update your information, please go to our website:
http://www.bt.cdc.gov/clinregistry

If you need further information or technical help, please send an e-mail message to: coca@cdc.gov

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    24 Hours/Every Day
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov

A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #